Chemokines and inflammation in the nasal passages of infants with respiratory syncytial virus bronchiolitis

被引:71
|
作者
Noah, TL
Ivins, SS
Murphy, P
Kazachkova, I
Moats-Staats, B
Henderson, FW
机构
[1] Univ N Carolina, Dept Pediat, Chapel Hill, NC 27599 USA
[2] Univ N Carolina, Ctr Environm Med & Lung Biol, Chapel Hill, NC 27599 USA
[3] Maimonides Hosp, Brooklyn, NY 11201 USA
[4] Univ N Carolina, Chapel Hill, NC 27599 USA
关键词
RSV; bronchiolitis; RANTES; IL-8; epithelium;
D O I
10.1006/clim.2002.5248
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
This study measured chemokines in nasal lavage fluids (NLF) from infants with respiratory syncytial virus (RSV) bronchiolitis, defined by lung hyperinflation and wheezing. Comparison was made to RSV-positive infants without bronchiolitis and RSV-negative infants with acute respiratory illnesses. RSV-positive illnesses were associated with increased epithelial shedding, increased RANTES/protein ratios, and increased IL-8/protein ratios in NLF compared to RSV-negative illnesses. Among RSV-positive infants, bronchiolitics had greater total cell counts and percentage epithelial cells in NLF than nonbronchiolitics. Bronchiolitics also had roughly twice the NLF RANTES/ IL-8 ratio than nonbronchiolitics (P =.043). Semiquantitative reverse transcriptase-polymerase chain reaction of nasal epithelium suggested similar RANTES/IL-8 ratio increases among bronchiolitics. A more mildly affected, RSV-positive outpatient population showed none of these differences. We conclude that RSV bronchiolitis is associated with a shift toward relatively more RANTES in nasal secretions of infants sick enough to require hospitalization, and mucosal epithelium may contribute to this process. Similar processes in the lower airways may enhance inflammation due to RANTES-responsive cell types and affect clinical manifestations. (C) 2002 Elsevier Science (USA).
引用
收藏
页码:86 / 95
页数:10
相关论文
共 50 条
  • [41] Respiratory Syncytial Virus Bronchiolitis in Children
    Verger, Judy Trivits
    Verger, Emily Elizabeth
    CRITICAL CARE NURSING CLINICS OF NORTH AMERICA, 2012, 24 (04) : 555 - +
  • [42] Prophylaxis for respiratory syncytial virus bronchiolitis
    Nadal, D
    Berger, C
    Aebi, C
    Kind, C
    LANCET, 1999, 354 (9194): : 1997 - 1997
  • [43] Bronchiolitis associated with respiratory syncytial virus
    Bellagra, N
    Hober, D
    Dewilde, A
    Lequien, P
    Wattre, P
    ANNALES DE BIOLOGIE CLINIQUE, 1997, 55 (03) : 243 - 243
  • [44] Colchicine for respiratory syncytial virus bronchiolitis
    Altschuter, EL
    LANCET, 2004, 363 (9424): : 1911 - 1911
  • [45] Immunopathogenesis of respiratory syncytial virus bronchiolitis
    Bennett, Berkeley L.
    Garofalo, Roberto P.
    Cron, Stanley G.
    Hosakote, Yashoda M.
    Atmar, Robert L.
    Macias, Charles G.
    Piedra, Pedro A.
    JOURNAL OF INFECTIOUS DISEASES, 2007, 195 (10): : 1532 - 1540
  • [46] Prevention of bronchiolitis in respiratory syncytial virus
    Marchac, Valentine
    ARCHIVES DE PEDIATRIE, 2006, 13 : S12 - S17
  • [47] Respiratory Syncytial Virus Infection and Bronchiolitis
    Piedimonte, Giovanni
    Perez, Miriam K.
    PEDIATRICS IN REVIEW, 2014, 35 (12) : 519 - 530
  • [48] Respiratory Syncytial Virus Bronchiolitis in Children
    Smith, Dustin K.
    Seales, Sajeewane
    Budzik, Carol
    AMERICAN FAMILY PHYSICIAN, 2017, 95 (02) : 94 - 99
  • [49] Increased tumor necrosis factor-α and endothelin-1 in nasal secretion of infants with respiratory syncytial virus bronchiolitis
    Chung, H
    Kim, S
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2006, 117 (02) : S316 - S316
  • [50] Eosinophil activation and cysteinyl leukotriene production in infants with respiratory syncytial virus bronchiolitis
    Dimova-Yaneva, D
    Russell, D
    Main, M
    Brooker, RJ
    Helms, PJ
    CLINICAL AND EXPERIMENTAL ALLERGY, 2004, 34 (04): : 555 - 558